Study: URTI symptoms reduced with PEA Levagen+

An industry funded study concludes the branded palmitoylethanolamide (PEA) ingredient ‘Levagen+’ is safe and effective in reducing the incidence and symptoms associated with upper respiratory tract infections (URTIs).

Related Keywords

Australia ,Amanda Rao ,Rachael Skinner ,Palmitoylethanolamide Levagen ,David Briskey , ,Pharmako Biotechnologies ,Upper Respiratory Tract Infection ,Double Blind ,Placebo Controlled Trial ,Research ,Supplements ,Covid 19 ,Proteins ,Eptides ,Amino Acids ,Immune Support ,Inflammation ,Respiratory Health ,Orti ,Sea ,Almitolethanolamide ,Gencor ,